Efficacy and safety of modified Xiaoyao-san in the treatment of postoperative depression of breast cancer: a systematic review and meta-analysis

Bozhen Huang, Hongyi Lan, Meijiao Zhou, Shanshan Song, Manman Zhang, Luyao Wang, Min Jiang · 2026

Read Efficacy and safety of modified Xiaoyao-san in the treatment of postoperative depression of breast cancer: a systematic review and meta-analysis by Bozhen Huang, Hongyi Lan, Meijiao Zhou, Shanshan Song, Manman Zhang, Luyao Wang, Min Jiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13563646.txt.

Description

Bozhen Huang and co-authors pool trials of a classic herbal formula against depression after breast cancer surgery, in a 2026 review. Modified Xiaoyao-san is a traditional Chinese prescription long used for mood troubles. The team searched eight databases for randomized trials in postoperative breast cancer patients. Eleven trials covering about seven hundred fifty patients met the bar, split evenly between formula and control arms.

Added to standard antidepressants, the formula eased depressive symptoms clearly more than antidepressants alone. Used by itself, it showed no clear edge over control care. Safety data were gathered alongside efficacy. The pattern argues for the formula as a partner therapy, not a replacement. Bigger, tighter trials would firm up the verdict.

Catalog record

CREATORBozhen Huang, Hongyi Lan, Meijiao Zhou, Shanshan Song, Manman Zhang, Luyao Wang, Min Jiang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13563646

Browse the full library · About the Tower of Babel